Optimal control of combined therapy in a single strain HIV-1 model

Electronic Journal of Differential Equations

Volumn 2005, Issue , 2005, Pages

  Garira, Winston ^a   Musekwa, Senelani D ^a   Shiri, Tinevimbo ^a  

^a NATIONAL UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Zimbabwe)

Author keywords

Combined therapy; HIV; Mathematical model; Optimal control

Indexed keywords

EID: 21244441432     PISSN: 10726691     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Ahr, B., Robert-Hebmann, V., Devaux, C. and Biard-Piechaczyk, M.; Apoptosis of uninfected cells induced by HIV envelope glycoproteins. Retrovirology. (2004), 1:12.
2. Altes, H. K., Price, D. A., Jansen, V. A. A.; Effector cytotoxic T lymphocyte numbers induced by vaccination should exceed levels in chronic infection for protection from HIV. Science. 20 (2001), 3-6.
3. Bajaria, H. S., Webb, G., Kirschner, E.D.; Predicting differential responses to structured treatment interruptions during HAART. Bulletin of Mathematical Biology. (2003), 1-26.
4. Butler, S., Kirschner, D., Lenhart, S.; Optimal control of chemotherapy affecting the infectivity of HIV. In: Arino O, Axelrod D, Kimmel M, Langlais M (eds): Advances in Mathematical Population Dynamics: Molecules, Cells, Man. World Scientific Publishing, (1997) 104-120.
5. Dixit, M. N., Perelson, S. A.; Complex patterns of viral load decay under antiretroviral therapy: influence of pharmacokinetics and intracellular delay. Journal of Theoretical Biology. 226 (2004), 95-109.
6. Fister, R., Lenhart S., McNally, J. S.; Optimizing chemotherapy in an HIV model. J. of Diff Egn. 32 (1998), 1-12.
7. Gallant, E. J.; Antiretroviral therapy update from the 44th ICAAC. The Johns Hopkins University AIDS Service. 17 (2005), 1-8.
8. Joshi, H. R.; Optimal Control of an HIV Immunology Model. Optim. Contr. Appl. Math 23 (2002), 199-213.
9. Kirschner, D.; Using mathematics to understand HIV immune dynamics. Notices Amer Math Soc. 43 (1996), 191-202.
10. Kirschner, D., Lenhart, S., Serbin, S.; Optimal control of the chemotherapy of HIV. Journal of Mathematical Biology. 35 (1997), 775-792.
11. Kirschner, E. D., Webb, F. G.; Immunotherapy of HIV-1 infection. Journal of Biological Systems. Vol. 6, No. 1 (1998), 71-83.
12. Klenerman, P., Wu, Y., Philips, R.; HIV: current opinion on escapology. Current Opinion in Microbiology. 5 (2002), 408-413.
13. Kot, M.; Elements of Mathematical Ecology. Cambridge University Press, 2001.
14. Krakauer, D. and Nowak, M. A.; T cell induced pathogenesis in HIV:bystander effects and latent infection. Proc. Royal Soc. London B. 266 (1999), 1069-1075.
15. Kutch, J.J., Gufll, P.; Optimal control of HIV infection with a continuously mutating viral population. Proceedings of the American Control Conference, (2002), 4033-4038.
16. Perelson, S. A.; Modelling viral and immune system dynamics. MacMillan Magazines Ltd. 2 (2002), 28-36.
17. Perelson, S. A., Kirschner, E. D., De Boer, R.; Dynamics of HIV-infection of CD4+ T cells. Mathematical Biosciences. 114: (1993), 81-125.
18. Sewell, A. K., Price, D. A., Oxenius, A., Kelleher, A. D., Phillips, R. E.; Cytotoxic T lymphocyte responses to human immunodeficiency virus: control and escape. Stem Cells. 18 (2000), 230-244.
19. Shim, H., Han, C. C., Chung, S.W., Nam, W. S., Seo, H. J.; Optimal scheduling of drug treatment for HIV infection: continuous dose control and receding horizon control. International Journal of Control, Automation, and Systems. 1, (2003), 401-407.
20. Wodarz, D., Nowak, A. M.; Immune responses and viral phenotype: do replication rate and cytopathogenecity influence virus load? Journal of Theoretical Medicine. 2 (2000), 113-127.